Hence, to detect any latent MPN, screening for the JAK2 V617F mutation was recommended in patients with major idiopathic abdominal vein thrombosis who have normal blood counts [76], but not in patients with arterial and venous thrombosis at usual sites [77]. Here, JAK2 is linked to myeloproliferative disorder.